Free Widgets | Feedback 
Live Share Markets - Appuonline.com


Updated:18 Oct 2017 03:31:00 PM(IST)

Investor Tool

My Stockwatch 

RELIANCE 914.50 [ +4.59% ]TCS 2586.60 [ -0.31% ]

Sensex32584.35
-24.81 -0.08%

Nifty10210.85
-23.60 -0.23%

Midcap16115.98
1.48 0.01%

Smallcap17063.39
-2.76 -0.02%


Bse Corporate Announcements Back
Lupin received tentative approval for the generic Combivir
Lupin received tentative approval for the generic Combivir Strides Acrolab already received the tentative approval Lupin received tentative approval for the Abbreviated New Drug Application (ANDA) from the US FDA (Food and Drug Administration) for the Lamivudine; Zidovudine 150 mg and 300 mg tablets. It was originally developed and marketed by the ViV Healthcare under the brand name drug Combivir. It is an antiretroviral drug indicative for the treatment of the HIV infection. Interestingly, Teva Pharmaceuticals already received the final approval. Further, Strides Acrolab has already received the tentative approval for the drug.

Market on Mobile
























Site Map  •  Mobile  •  Companies  •  Learning Centre  •  Insurance •  About  •  Contact us  •  Disclaimer
© appuonline.com